AzTrials
AzTrials

Behavior, AdolescentBGW In-PersonNCT06557317

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

A study testing Black Girls for Wellness In-Person in people with Behavior, Adolescent and Childhood Obesity, run by Cornell University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program. Read more about this study

Who is it for?
Ages 12 to 18 years, women only
What is being tested?
Black Girls for Wellness In-Person
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
Aug 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • 12-18 years of age
  • self-identify as Black or African American
  • have obesity (>=95th percentile BMI)
  • 18 years or older.
  • proficiency in speaking English.
  • live in the same household as the adolescent who will also be enrolled.
  • prepares the majority (>50%) of meals in the household.

Who cannot join

  • pregnant or within 3 months postpartum.
  • participated in a formal weight management program within 6 months prior to study.
  • currently taking medications or diagnosed with a condition known to influence metabolism, physical activity ability, or cognitive function.
  • have previously undergone bariatric surgery.
  • have type 2 diabetes.
  • unable to speak English or have developmental conditions that interfere with ability to communicate.
  • pregnant or within 3 months postpartum.
  • unable to speak English or have developmental conditions that interfere with ability to communicate.

Trial locations and contacts

1 site in 1 country.

Tashara M Leak, PhD, RD contact

607-255-7664

tml226@cornell.edu

United States1 site, 1 recruiting
  • Brownsville Neighborhood Health Action Center

    Brooklyn, New York, 11212

    Elana Martins, 718-312-6135, emartin8@health.nyc.gov

    Recruiting

Other trials in United States

About this study

Official title: Examining the Preliminary Efficacy of an In-Person Lifestyle Intervention for Black Female Adolescent/Caregiver Dyads at Risk for Type 2 Diabetes Mellitus

The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program.

Read the detailed description

Enrolled adolescent/caregiver dyads will participate in the 12-week program. Each week, participants will engage in 2 activities: an in-person Wellness Session and an at-home cooking experience using ingredients provided at the Wellness Session.

The study will examine the pre-post difference in overall diet quality, dermal carotenoid levels, physical activity, body composition, and glycemic measures among at-risk black adolescent girls and their caregivers. Investigators hypothesize that after the program, participants' diets will be higher in quality than before.

Being tested
Black Girls for Wellness In-Person
Keywords
Adolescents, In-Person Lifestyle Program, Diabetes prevention, Black girls, Obesity
Medical subject headings
Adolescent Behavior, Pediatric Obesity, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders, Metabolic Diseases, Endocrine System Diseases, Overweight, Overnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Black Girls for Wellness In-PersonBehavioural

    Weekly for 12 weeks, adolescent/caregiver dyads will attend 1) an in-person Wellness Session (mindfulness, nutrition lesson, dance class, program reflection) (90 min/wk) and 2) a home cooking experience using ingredients provided at the Wellness Session (60 min/wk).

Study groups in NCT06557317
Study groupRoleWhat they receive
Intervention Adolescent/Caregiver DyadsExperimentalAdolescent/Caregiver dyads receive 12-week in-person lifestyle program consisting of a Wellness session, Dance Classes, and an at-home Cooking Experience.
Receives: Behavioral: Black Girls for Wellness In-Person

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in diet quality of adolescent participants, as measured by the Healthy Eating Index Scores

    Scores are calculated from three 24-hour diet records, range from 0-100. Higher score reflects that higher alignment between one's diet and dietary recommendations from the Dietary Guidelines for Americans.

    Measured: Baseline, 12 weeks [end of study]

Secondary outcomes (10)
  1. Change in dermal carotenoids level

    Scores are measured using the Veggie Meter device, range from 0-800. Higher score acts as proxy for fruits and vegetables consumption.

    Measured: Baseline, 12 weeks [end of study]

  2. Change in percent time sedentary

    Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days. Percent time spent on sedentary will be calculated.

    Measured: Baseline, 12 weeks [end of study]

  3. Change in percent time spent in light activity

    Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days. Percent time spent in light activity will be calculated.

    Measured: Baseline, 12 weeks [end of study]

  4. Change in percent time spent in moderate to vigorous activity

    Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days. Percent time spent in moderate and vigorous activity will be calculated.

    Measured: Baseline, 12 weeks [end of study]

  5. Change in HbA1c

    HbA1c will be assessed through a blood draw.

    Measured: Baseline, 12 weeks [end of study]

  6. Change in lipid profile

    Total, high-density, low-density cholesterol, and triglycerides will be assessed through a blood draws.

    Measured: Baseline, 12 weeks [end of study]

  7. Change in body mass index

    Height will be measured using a stadiometer to the nearest decimal point in cm. Weight will be measured using a scale to the nearest decimal in kg. Body mass index will be calculated using kg/m^2.

    Measured: Baseline, 12 weeks [end of study]

  8. Change in body fat percentage

    Body fat percentage will be measured using a scale to the nearest decimal.

    Measured: Baseline, 12 weeks [end of study]

  9. Change in waist circumference

    Waist circumference will be measured using a waist circumference tape to the nearest decimal in cm.

    Measured: Baseline, 12 weeks [end of study]

  10. Change in high blood pressure status

    Blood pressure will be measured using blood pressure monitors. High blood pressure is considered as reading of >=120/80.

    Measured: Baseline, 12 weeks [end of study]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2024
  2. Study startAug 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06557317
Sponsor's protocol ID
0148278
Acronym
BGW In-Person
Status last verified
Aug 2024
First submitted
14 Aug 2024
Last updated
16 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Black Girls for Wellness In-Person in people with Behavior, Adolescent and Childhood Obesity, run by Cornell University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tashara M Leak, PhD, RD (607-255-7664, tml226@cornell.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in diet quality of adolescent participants, as measured by the Healthy Eating Index Scores (time frame: Baseline, 12 weeks [end of study]). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in